WebApr 11, 2024 · Sponsors must upload a lay summary that will then be publicly accessible through the Clinical Trials Information System (CTIS). After a transition period of 3 years, the submission of lay summary to the CTIS will be mandatory from 31 January 2025 onwards for all clinical trials, both ongoing and new ones (Picture 1). 4 WebI am a Board Certified Pharmacotherapy Pharmacist, AUC Lean Six Sigma Yellow Belt Certified, GCP certified. Highly experienced in the field of …
The new Clinical Trials Regulation - what you need to know now
WebClinical Trials Information System - CTIS Compassionate Use GCP Inspections Unit Licensing Types of Marketing Authorisation Licensing Procedures Follow-up Procedures Issues Relevant for Licensing Medicines for children Medicines for rare diseases Pharmacovigilance Reporting risks Risk information Periodic Safety Update Reports … WebDisclosure rules of clinical trial information in CTIS • Only applications on which a decision (any decision) has been reached by the Member State Concerned will be made public; • All data and documents in the CTIS will be made public, with few exceptions; • The default is always to make public at the first opportunity; olympic men\\u0027s snowboard slopestyle full
EU Clinical Trial Regulation: Get Ready to Adapt!
WebThe Clinical Trials Regulation foresees a 3-year transition period to CTIS. From 31 January 2024 until 31 January 2024, clinical trial sponsors can choose to submit their clinical … WebJoin to apply for the Senior / Principal, Auditor, Quality Assurance role at CTI Clinical Trial and Consulting Services. First name. Last name. Email. Password (8+ characters) WebOct 8, 2024 · CTIS is designed to have an application programming interface (API) that allows member states to access information contained in the database; most data submitted through the portal will be publicly accessible unless otherwise protected under the EU’s clinical trials regulation. olympic men\u0027s soccer results